Bruker Spatial Biology, a division of Bruker Corporation, is expanding its collaboration with Noetik Inc. to advance tissue foundation models for translational and therapeutic applications. Building on a prior study of more than 3,500 patient samples using Bruker’s CosMx Spatial Molecular Imager, Noetik will image thousands more patients with the CosMx whole transcriptome assay to train large-scale spatial AI “world models” for oncology and drug discovery.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202602240700BIZWIRE_USPR_____20260224_BW789530) on February 24, 2026, and is solely responsible for the information contained therein.
Comments